Free Trial

Immunovant (IMVT) Earnings Date, Estimates & Call Transcripts

Immunovant logo
$15.20 -0.69 (-4.34%)
Closing price 04:00 PM Eastern
Extended Trading
$15.20 0.00 (0.00%)
As of 06:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immunovant Earnings Summary

Immunovant released Q1 2026 earnings on August 11, 2025, reporting an EPS of -$0.60, which topped analysts' consensus estimates of -$0.69 by $0.09. With a trailing EPS of -$2.85, Immunovant's earnings are expected to decrease next year, from ($2.69) to ($3.08) per share.

Latest Q1
Earnings Date
Aug. 11Estimated
Consensus EPS
(Aug. 11)
-$0.69
Actual EPS
(Aug. 11)
-$0.60 Beat By $0.09

Q1 2026 Earnings Resources

Get Immunovant Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Immunovant and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

IMVT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Immunovant Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20253-$0.57-$0.41-$0.50
Q2 20254-$0.62-$0.54-$0.59
Q3 20254-$0.64-$0.54-$0.59
Q4 20254-$0.75-$0.56-$0.65
FY 2025 15 -$2.58 -$2.05 -$2.32
Q1 20262-$0.82-$0.62-$0.72
Q2 20264-$0.87-$0.70-$0.77
Q3 20264-$0.86-$0.70-$0.78
Q4 20264-$0.88-$0.70-$0.78
FY 2026 14 -$3.43 -$2.72 -$3.05
Q1 20272-$0.91-$0.87-$0.89
Q2 20272-$0.95-$0.89-$0.92
Q3 20272-$0.96-$0.91-$0.94
Q4 20271-$0.92-$0.92-$0.92

Immunovant Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/11/2025Q1 2026-$0.69-$0.60+$0.09-$0.71--
5/29/2025Q4 2025-$0.72-$0.64+$0.08-$0.64-$0.16M
2/10/2025Q3 2025-$0.68-$0.76 -$0.08-$0.76--
11/7/2024Q2 2025-$0.59-$0.74 -$0.15-$0.74--
8/6/2024Q1 2025-$0.53-$0.60 -$0.07-$0.60--
5/29/2024Q4 2024-$0.44-$0.52 -$0.08-$0.52--
2/12/2024Q3 2024-$0.43-$0.36+$0.07-$0.36--
11/9/2023Q2 2024-$0.45-$0.45--$0.45--

Immunovant Earnings - Frequently Asked Questions

Immunovant (NASDAQ:IMVT) last announced its quarterly earning data on Monday, August 11, 2025. Learn more on IMVT's earnings history.

In the previous quarter, Immunovant (NASDAQ:IMVT) reported ($0.60) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.69) by $0.09. Learn more on analysts' earnings estimate vs. IMVT's actual earnings.

Immunovant's earnings report can be found in their filing with the SEC.
View SEC filing

Immunovant (NASDAQ:IMVT) has a recorded net income of -$413.84 million. IMVT has generated -$2.85 earnings per share over the last four quarters.

Immunovant's earnings are expected to decrease from ($2.69) per share to ($3.08) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:IMVT) was last updated on 8/14/2025 by MarketBeat.com Staff
From Our Partners